company background image
DVA

DaVita NYSE:DVA Stock Report

Last Price

US$73.92

Market Cap

US$6.7b

7D

4.6%

1Y

-24.0%

Updated

27 Nov, 2022

Data

Company Financials +
DVA fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance2/6
Financial Health2/6
Dividends0/6

DVA Stock Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure.

DaVita Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for DaVita
Historical stock prices
Current Share PriceUS$73.92
52 Week HighUS$124.81
52 Week LowUS$65.28
Beta1
1 Month Change4.79%
3 Month Change-16.90%
1 Year Change-24.02%
3 Year Change3.00%
5 Year Change20.96%
Change since IPO1,713.98%

Recent News & Updates

DaVita Q3 2022 Earnings Preview

Oct 27

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Oct 18
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Recent updates

Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

Oct 18
Is Now The Time To Look At Buying DaVita Inc. (NYSE:DVA)?

We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt

Aug 14
We Think DaVita (NYSE:DVA) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Jul 13
Is It Too Late To Consider Buying DaVita Inc. (NYSE:DVA)?

Here's Why I Think DaVita (NYSE:DVA) Is An Interesting Stock

May 15
Here's Why I Think DaVita (NYSE:DVA) Is An Interesting Stock

Here's Why DaVita (NYSE:DVA) Has A Meaningful Debt Burden

Apr 29
Here's Why DaVita (NYSE:DVA) Has A Meaningful Debt Burden

Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?

Apr 14
Is It Time To Consider Buying DaVita Inc. (NYSE:DVA)?

Do DaVita's (NYSE:DVA) Earnings Warrant Your Attention?

Feb 11
Do DaVita's (NYSE:DVA) Earnings Warrant Your Attention?

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Jan 29
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

When Should You Buy DaVita Inc. (NYSE:DVA)?

Jan 14
When Should You Buy DaVita Inc. (NYSE:DVA)?

Is DaVita Inc. (NYSE:DVA) Trading At A 48% Discount?

Dec 31
Is DaVita Inc. (NYSE:DVA) Trading At A 48% Discount?

DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

Oct 29
DaVita (NYSE:DVA) Has A Somewhat Strained Balance Sheet

Does DaVita (NYSE:DVA) Deserve A Spot On Your Watchlist?

Oct 14
Does DaVita (NYSE:DVA) Deserve A Spot On Your Watchlist?

At US$121, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?

Sep 29
At US$121, Is DaVita Inc. (NYSE:DVA) Worth Looking At Closely?

Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 32%?

Aug 21
Are Investors Undervaluing DaVita Inc. (NYSE:DVA) By 32%?

Is DaVita (NYSE:DVA) Using Too Much Debt?

Jul 30
Is DaVita (NYSE:DVA) Using Too Much Debt?

Should You Be Adding DaVita (NYSE:DVA) To Your Watchlist Today?

Mar 30
Should You Be Adding DaVita (NYSE:DVA) To Your Watchlist Today?

Have Insiders Been Selling DaVita Inc. (NYSE:DVA) Shares?

Feb 28
Have Insiders Been Selling DaVita Inc. (NYSE:DVA) Shares?

DaVita Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Feb 13
DaVita Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Should You Investigate DaVita Inc. (NYSE:DVA) At US$117?

Jan 31
Should You Investigate DaVita Inc. (NYSE:DVA) At US$117?

Is DaVita (NYSE:DVA) A Risky Investment?

Jan 16
Is DaVita (NYSE:DVA) A Risky Investment?

Should We Be Delighted With DaVita Inc.'s (NYSE:DVA) ROE Of 34%?

Jan 01
Should We Be Delighted With DaVita Inc.'s (NYSE:DVA) ROE Of 34%?

Can You Imagine How DaVita's (NYSE:DVA) Shareholders Feel About The 62% Share Price Increase?

Dec 16
Can You Imagine How DaVita's (NYSE:DVA) Shareholders Feel About The 62% Share Price Increase?

DaVita Inc. (NYSE:DVA) Shares Could Be 26% Below Their Intrinsic Value Estimate

Dec 01
DaVita Inc. (NYSE:DVA) Shares Could Be 26% Below Their Intrinsic Value Estimate

Shareholder Returns

DVAUS HealthcareUS Market
7D4.6%2.1%1.3%
1Y-24.0%9.3%-18.5%

Return vs Industry: DVA underperformed the US Healthcare industry which returned 9.3% over the past year.

Return vs Market: DVA underperformed the US Market which returned -18.5% over the past year.

Price Volatility

Is DVA's price volatile compared to industry and market?
DVA volatility
DVA Average Weekly Movement9.2%
Healthcare Industry Average Movement8.2%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: DVA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: DVA's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199469,000Javier Rodriguezhttps://www.davita.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

DaVita Inc. Fundamentals Summary

How do DaVita's earnings and revenue compare to its market cap?
DVA fundamental statistics
Market CapUS$6.66b
Earnings (TTM)US$679.77m
Revenue (TTM)US$11.64b

9.8x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
DVA income statement (TTM)
RevenueUS$11.64b
Cost of RevenueUS$8.18b
Gross ProfitUS$3.46b
Other ExpensesUS$2.78b
EarningsUS$679.77m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)7.54
Gross Margin29.70%
Net Profit Margin5.84%
Debt/Equity Ratio424.6%

How did DVA perform over the long term?

See historical performance and comparison